n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors

The Risk and Prevention Study Collaborative Group·2013·New England Journal of Medicine
DOI 10.1056/nejmoa1205409

Cited by (511)

Items 101–200 of 511

  1. ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4
    Timothy D. O’Connell, Robert Block, Shue Huang, Gregory C. Shearer · 2016 · Journal of Molecular and Cellular Cardiology
  2. Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials
    Wang, Tianjiao, Zhang, Xin, Zhou, Na, Shen, Yuxuan, Li, Biao, Chen, Bingshu E., Li, Xinzhi · 2023 · Journal of the American Heart Association
  3. Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Heart Failure: Current Understanding for Basic to Clinical Relevance
    Sakamoto, Atsushi, Saotome, Masao, Iguchi, Keisuke, Maekawa, Yuichiro · 2019 · International Journal of Molecular Sciences
  4. Red blood cell polyunsaturated fatty acids and mortality in the Women's Health Initiative Memory Study
    William Stephen Harris, Juhua Luo, James V. Pottala, Mark Andrew Espeland, Karen L. Margolis, JoAnn E. Manson, Lu Wang, Theodore M. Brasky, Jennifer G. Robinson · 2017 · Journal of clinical lipidology
  5. Exercise and diet in the management of nonalcoholic fatty liver disease
    Suzanne E. Mahady, Jacob George · 2015 · Metabolism
  6. Omega-3 Fatty Acids in Atherosclerosis and Coronary Artery Disease
    Magnus Bäck · 2017 · Future Science OA
  7. Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials
    Lombardi, Marco, Carbone, Salvatore, Del Buono, Marco Giuseppe, Chiabrando, Juan Guido, Vescovo, Giovanni Maria, Camilli, Massimiliano, Montone, Rocco Antonio, Vergallo, Rocco, Abbate, Antonio, Biondi-Zoccai, Giuseppe et al. · 2021 · European Heart Journal - Cardiovascular Pharmacotherapy
  8. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid
    M. John Chapman, José Luís Zamorano, Klaus Georg Parhofer · 2022 · Pharmacology & Therapeutics
  9. Our landscapes, our livestock, ourselves: Restoring broken linkages among plants, herbivores, and humans with diets that nourish and satiate
    Frederick D. Provenza, Michel Meuret, Pablo Gregorini · 2015 · Appetite
  10. Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids
    Peter L. McLennan · 2014 · European Journal of Applied Physiology
  11. Nonstatin Therapies for Management of Dyslipidemia: A Review
    Karen R Sando, Michelle Knight · 2015 · Clinical Therapeutics
  12. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: A review of the literature
    Matthew K. Ito · 2015 · Atherosclerosis
  13. Prevalence of US Adults with Triglycerides ≥ 150 mg/dl: NHANES 2007–2014
    Wenjun Fan, Sephy Philip, Craig B. Granowitz, Peter Paul Toth, Nathan D. Wong · 2020 · Cardiology and Therapy
  14. Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE)
    ORIGIN Trial Investigators · 2015 · Diabetes Care
  15. Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction
    Qiyuan Keith Liu · 2021 · Journal of clinical lipidology
  16. Omega-3 Fatty Acid Supplementation and Coronary Heart Disease Risks: A Meta-Analysis of Randomized Controlled Clinical Trials
    Shichun Shen, Gong Chen, Kaiqin Jin, Lei Zhou, Yin Xiao, Likun Ma · 2022 · Frontiers in Nutrition
  17. Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera
    Tiziano Barbui, Alessandro Maria Vannucchi, Valerio De Stefano, Alessandra Carobbio, Arianna Ghirardi, Greta Carioli, Arianna Masciulli, Elena Rossi, Fabio Ciceri, Massimiliano Bonifacio et al. · 2023 · NEJM Evidence
  18. Fish oil (n-3 fatty acids) in drug resistant epilepsy: a randomised placebo-controlled crossover study
    Christopher M. DeGiorgio, Patrick R Miller, Ronald M. Harper, JEFFREY A. GORNBEIN, Lara M. Schrader, Jason R. Soss, Sheba Meymandi · 2014 · Journal of Neurology Neurosurgery & Psychiatry
  19. Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids
    Weinberg, Richard L., Brook, Robert D., Rubenfire, Melvyn, Eagle, Kim A. · 2021 · Journal of the American College of Cardiology
  20. Plasma Phospholipid PUFAs Are Associated with Greater Muscle and Knee Extension Strength but Not with Changes in Muscle Parameters in Older Adults
    Ilse Reinders, Xiaoling Song, Marjolein Visser, Guðný Eiríksdóttir, Vilmundur G. Gudnason, Sigurdur Oli Sigurdsson, Thor Aspelund, Kristín Siggeirsdóttir, Ingeborg A. Brouwer, Tamara B. Harris et al. · 2014 · Journal of Nutrition
  21. Impact of Genotype on EPA and DHA Status and Responsiveness to Increased Intakes
    Anne Marie Minihane · 2016 · Nutrients
  22. Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in Diabetes
    Anastasia‐Stefania Alexopoulos, Ali Qamar, Kathryn Hutchins, Matthew J. Crowley, Bryan C. Batch, John R. Guyton · 2019 · Current Diabetes Reports
  23. Recent Clinical Trials Shed New Light on the Cardiovascular Benefits of Omega-3 Fatty Acids
    Penny M. Kris‐Etherton, Chesney K. Richter, Kate J. Bowen, Ann C. Skulas‐Ray, Kristina Harris Jackson, Kristina S. Petersen, William Stephen Harris · 2019 · Methodist DeBakey Cardiovascular Journal
  24. Dietary and Pharmacological Fatty Acids and Cardiovascular Health
    Wu, Huaizhu, Xu, Lu, Ballantyne, Christie M · 2020 · The Journal of Clinical Endocrinology & Metabolism
  25. Pharmacological agents for NASH
    Vlad Ratziu · 2013 · Nature Reviews Gastroenterology & Hepatology
  26. Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis
    Evangelos C. Rizos, Georgios Markozannes, Απόστολος Τσάπας, Christos Socrates Mantzoros, Evangelia Ntzani · 2020 · Heart
  27. Using High-Dose Omega-3 Fatty Acid Supplements to Lower Triglyceride Levels in 10- to 19-Year-Olds
    de Ferranti, Sarah D., Milliren, Carly E., Denhoff, Erica R., Steltz, Sarah K., Selamet Tierney, Elif Seda, Feldman, Henry A., Osganian, Stavroula K. · 2014 · Clinical Pediatrics
  28. Bleeding risk in patients receiving omega-3 polyunsaturated fatty acids: a systematic review and meta-analysis of randomized clinical trials
    Javaid, Mustafa, Kadhim, Kadhim, Bawamia, Bilal, Cartlidge, Timothy, Farag, Mohamed, Alkhalil, Mohammad · 2024 · Journal of the American Heart Association
  29. Functional foods and cardiometabolic diseases
    Gerd Assmann, Pasqualina Buono, Aurora Daniele, Elisabetta Della Valle, Eduardo Farinaro, Gordon A. Ferns, Vittorio Krogh, Daan Kromhout, L. Masana, Jordi Merino et al. · 2014 · Nutrition Metabolism and Cardiovascular Diseases
  30. A Double-Blind Randomized Trial of Fish Oil to Lower Triglycerides and Improve Cardiometabolic Risk in Adolescents
    Gidding, Samuel S., Prospero, Carol, Hossain, Jobayer, Zappalla, Frances, Balagopal, Prabhakaran (Babu), Falkner, Bonita, Kwiterovich, Peter · 2014 · The Journal of Pediatrics
  31. Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014
    Harry Benjamin Rice, Aldo A. Bernasconi, Kevin Carl Maki, William Stephen Harris, Clemens von Schacky, Philip C. Calder · 2016 · Prostaglandins Leukotrienes and Essential Fatty Acids
  32. Combined dyslipidemia in childhood
    Rae-Ellen Webb Kavey · 2015 · Journal of clinical lipidology
  33. Risk of cardiovascular events in patients with hypertriglyceridaemia: A review of real‐world evidence
    Peter Paul Toth, Sergio Fazio, Nathan D. Wong, MICHAEL L. HULL, Gregory A. Nichols · 2019 · Diabetes Obesity and Metabolism
  34. Lipid Metabolite Biomarkers in Cardiovascular Disease: Discovery and Biomechanism Translation from Human Studies
    Peter McGranaghan, Jennifer Kirwan, Mariel A. García-Rivera, Burkert Mathias Pieske, Frank Edelmann, Florian Blaschke, Sandeep Appunni, Anshul Saxena, Muni Rubens, Emir Veledar et al. · 2021 · Metabolites
  35. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: Do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials
    Casula, Manuela, Olmastroni, Elena, Gazzotti, Marta, Galimberti, Federica, Zambon, Alberto, Catapano, Alberico L. · 2020 · Pharmacological Research
  36. Long chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in Japanese men in Japan and white men in the USA: population based prospective cohort study
    Akira M Sekikawa, Katsuyuki Miura, Sunghee Lee, Akira Fujiyoshi, Daniel Edmundowicz, Takashi Kadowaki, Roger G. Evans, Sayaka Kadowaki, Kim Sutton-Tyrrell, Tomonori Okamura et al. · 2013 · Heart
  37. Fish-oil emulsion (omega-3 polyunsaturated fatty acids) attenuates acute lung injury induced by intestinal ischemia–reperfusion through Adenosine 5′-monophosphate-activated protein kinase–sirtuin1 pathway
    Huirong Jing, Jihong Yao, Xingming Liu, Hui Jie Fan, Feng Zhang, Zhenlu Li, Xiaofeng Tian, Yun Zhou · 2013 · Journal of Surgical Research
  38. Dietary fried fish intake increases risk of CVD: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study
    Fadi B. Nahab, Keith E. Pearson, Michael Frankel, Jamy D. Ard, Monika M. Safford, Dawn Kleindorfer, Virginia J. Howard, Suzanne E. Judd · 2016 · Public Health Nutrition
  39. Triglycerides, Atherosclerosis, and Cardiovascular Outcome Studies: Focus on Omega-3 Fatty Acids
    Yehuda Handelsman, Michael David Shapiro · 2016 · Endocrine Practice
  40. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate
    Yan Qin, Hilde Nyheim, Else Marie Haram, Joseph M. Moritz, Svein Olaf Hustvedt · 2017 · Lipids in Health and Disease
  41. Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention
    Marcello Arca, Claudio Borghi, Roberto Pontremoli, Gaetano Maria De Ferrari, Furio Colivicchi, Giovambattista Desideri, Pier Luigi Temporelli · 2017 · Nutrition Metabolism and Cardiovascular Diseases
  42. Docosahexaenoic acid lowers cardiac mitochondrial enzyme activity by replacing linoleic acid in the phospholipidome
    E. Madison Sullivan, Edward Ross Pennington, Genevieve C. Sparagna, Maria J. Torres, Peter Darrell Neufer, Mitchel Harris, James Washington, Ethan J. Anderson, Tonya N. Zeczycki, David A. Brown et al. · 2017 · Journal of Biological Chemistry
  43. Pitfalls in the use of randomised controlled trials for fish oil studies with cardiac patients
    Michael J. James, Thomas Sullivan, Robert G. Metcalf, Leslie G. Cleland · 2014 · British Journal Of Nutrition
  44. Nutrient reference value: non-communicable disease endpoints—a conference report
    J. R. Lupton, Jeffrey B. Blumberg, Mary R. L’Abbé, M. LeDoux, Harry Benjamin Rice, Clemens von Schacky, Ann L. Yaktine, James C. Griffiths · 2016 · European Journal of Nutrition
  45. Omega-3 Fatty Acids in Cardiovascular Disease and Diabetes: a Review of Recent Evidence
    Salman Zahoor Bhat, Sudipa Sarkar, Duha Zaffar, Paresh Dandona, Rita Rastogi Kalyani · 2023 · Current Cardiology Reports
  46. Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake by Ethnicity, Income, and Education Level in the United States: NHANES 2003–2014
    Caleb Cave, Nicholas A. Hein, Lynette M. Smith, Ann Anderson‐Berry, Chesney K. Richter, Karl Stessy Bisselou, Adams K. Appiah, Penny M. Kris‐Etherton, Ann C. Skulas‐Ray, Maranda K. Thompson et al. · 2020 · Nutrients
  47. A fish-based diet intervention improves endothelial function in postmenopausal women with type 2 diabetes mellitus: A randomized crossover trial
    Keiko Kondo, Katsutaro Morino, Yoshihiko Nishio, Motoyuki Kondo, Keiko Nakao, Fumiyuki Nakagawa, Atsushi Ishikado, Osamu Sekine, Takeshi Yoshizaki, Atsunori Kashiwagi et al. · 2014 · Metabolism
  48. Advancing beyond the “heart-healthy diet” for peripheral arterial disease
    Emily V. Nosova, Michael S. Conte, S. Marlene Grenon · 2014 · Journal of Vascular Surgery
  49. A Comparative Overview of Prescription Omega-3 Fatty Acid Products.
    Matthew K. Ito · 2015 · PubMed Central
  50. Elevated triglycerides and low high-density lipoprotein cholesterol level as marker of very high risk in type 2 diabetes
    Michel Paul Hermans, Paul Elie Valensi · 2018 · Current Opinion in Endocrinology Diabetes and Obesity
  51. Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system
    Ahmed M. Darwesh, Deanna K. Sosnowski, Tim YT. Lee, Hedieh Keshavarz-Bahaghighat, John M. Seubert · 2019 · Chemico-Biological Interactions
  52. Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis
    Jie Rong Yan, Ming Liu, Danning Yang, Yu Zhang, Fengshuang An · 2022 · Cardiovascular Drugs and Therapy
  53. Effects of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation on Cardiovascular Mortality: The Importance of the Dose of DHA
    Barbara J. Meyer, Renate H. M. de Groot · 2017 · Nutrients
  54. ω-3 Fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: new pieces in a complex puzzle
    Wu, Jason H Y, Mozaffarian, Dariush · 2014 · Heart
  55. A point mutation in the human Slo1 channel that impairs its sensitivity to omega-3 docosahexaenoic acid
    Toshinori Hoshi, Rong Xu, Shangwei Hou, Stefan H. Heinemann, Yutao Tian · 2013 · The Journal of General Physiology
  56. Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials
    Linlin Huang, Fanjie Zhang, Ping Xu, Yijie Zhou, Yijun Liu, Hongdie Zhang, Xiaozhen Tan, Xinxu Ge, Yong Xu, Man Guo et al. · 2023 · Advances in Nutrition
  57. The Role of Resolvins: EPA and DHA Derivatives Can Be Useful in the Prevention and Treatment of Ischemic Stroke
    Nikola Tułowiecka, Dariusz Kotlęga, Piotr Prowans, Małgorzata Szczuko · 2020 · International Journal of Molecular Sciences
  58. Continuous decline in mortality from coronary heart disease in Japan despite a continuous and marked rise in total cholesterol: Japanese experience after the Seven Countries Study
    Sekikawa, Akira, Miyamoto, Yoshihiro, Miura, Katsuyuki, Nishimura, Kunihiro, Willcox, Bradley J, Masaki, Kamal H, Rodriguez, Beatriz, Tracy, Russell P, Okamura, Tomonori, Kuller, Lewis H · 2015 · International Journal of Epidemiology
  59. Dietary treatment to lower cholesterol and triglyceride and reduce cardiovascular risk
    Francine K. Welty · 2020 · Current Opinion in Lipidology
  60. Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites
    Timothy D. O’Connell, Richard Preston Mason, Matthew Jay Budoff, Ann Marie Návar, Gregory C. Shearer · 2020 · European Heart Journal Supplements
  61. Inflammatory and Oxidative Stress Markers in Skeletal Muscle of Obese Subjects
    Victoria Catalán, Gema Frühbeck, Javier Gómez‐Ambrosi · 2018 · Elsevier eBooks
  62. Omega-3 Fatty Acids in Arterial Hypertension: Is There Any Good News?
    Gabriele Brosolo, Andrea Da Porto, Stefano Marcante, Alessandro Picci, Filippo Capilupi, Patrizio Capilupi, Nicole Bertin, Cinzia Vivarelli, Luca Bulfone, Antonio Vacca et al. · 2023 · International Journal of Molecular Sciences
  63. Protective effects of dietary PUFA against chronic disease: evidence from epidemiological studies and intervention trials
    T. A. B. Sanders · 2013 · Proceedings of The Nutrition Society
  64. Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and docosahexaenoic acid in the prevention of cardiovascular diseases: a review of the state-of-the-art
    Yasuhiro Watanabe, Ichiro Tatsuno · 2020 · Expert Review of Clinical Pharmacology
  65. Endogenously Generated Omega‐3 Fatty Acids Attenuate Vascular Inflammation and Neointimal Hyperplasia by Interaction With Free Fatty Acid Receptor 4 in Mice
    Xinzhi Li, Laurel L. Ballantyne, Xinghui Che, Jeffrey D. Mewburn, Jing Xuan Kang, Robert M. Barkley, Robert C. Murphy, Ying Yu, Colin D. Funk · 2015 · Journal of the American Heart Association
  66. Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of a randomized control trial and an observational biomarker study
    Nishizaki, Yuji, Miyauchi, Katsumi, Iwata, Hiroshi, Inoue, Teruo, Hirayama, Atsushi, Kimura, Kazuo, Ozaki, Yukio, Murohara, Toyoaki, Ueshima, Kenji, Kuwabara, Yoshihiro et al. · 2023 · American Heart Journal
  67. Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia
    Bashir, Bilal, Schofield, Jonathan, Downie, Paul, France, Michael, Ashcroft, Darren M., Wright, Alison K., Romeo, Stefano, Gouni-Berthold, Ioanna, Maan, Akhlaq, Durrington, Paul N. et al. · 2024 · Frontiers in Cardiovascular Medicine
  68. The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia
    Dick C. Chan, P. Hugh R. Barrett, Gerald Francis Watts · 2013 · Best Practice & Research Clinical Endocrinology & Metabolism
  69. Omega-3 fatty acid and cardiovascular outcomes: insights from recent clinical trials
    Jia, Xiaoming, Kohli, Payal, Virani, Salim S. · 2019 · Current Atherosclerosis Reports
  70. Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids
    Megan F. Burke, Frances M. Burke, Daniel E. Soffer · 2017 · Current Atherosclerosis Reports
  71. [CONSENSUS ON FATS AND OILS IN THE DIET OF S ISH ADULTS; POSITION PAPER OF THE SPANISH FEDERATION OF FOOD, NUTRITION AND DIETETICS SOCIETIES].
    Emilio Ros, José López‐Miranda, Catalina Picó, Miguel Ángel Rubio, Nancy Babió, Aleix Sala‐Vila, Francisco Pérez‐Jiménez, Eduard Escrich, Mònica Bulló, Montserrat Solanas et al. · 2015 · PubMed
  72. Effects of krill oil and lean and fatty fish on cardiovascular risk markers: a randomised controlled trial
    Amanda Rundblad, Kirsten Bjørklund Holven, Inge Alexander Bruheim, Mari C. W. Myhrstad, Stine Marie Ulven · 2018 · Journal of Nutritional Science
  73. Fasting triglycerides are positively associated with cardiovascular mortality risk in people with diabetes
    Yutang Wang, Yan Fang, Dianna J. Magliano, Fadi Joseph Charchar, Christopher Graeme Sobey, Grant Raymond Drummond, Jonathan Golledge · 2022 · Cardiovascular Research
  74. Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Heart Failure trial
    William Stephen Harris, Serge Masson, Simona Barlera, Valentina Milani, Silvana Pileggi, Maria Grazia Franzosi, Roberto Marchioli, Gianni Tognoni, Luigi Tavazzi, Roberto Latini · 2016 · Nutrition Research
  75. Omega 3 fatty acids in cardiovascular disease risk factors: An updated systematic review of randomised clinical trials
    Óscar Daniel Rangel-Huerta, Ángel Gil · 2017 · Clinical Nutrition
  76. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Akira M Sekikawa, Chendi Cui, Daisuke Sugiyama, Anthony Fabio, William Stephen Harris, Xiao Zhang · 2019 · Nutrients
  77. Type 2 Diabetes Mellitus, Metabolic Syndrome, and Mixed Dyslipidemia: How Similar, How Different, and How to Treat?
    Julian Halcox, Anoop Misra · 2014 · Metabolic Syndrome and Related Disorders
  78. Bioactive compounds as an alternative for drug co-therapy: Overcoming challenges in cardiovascular disease prevention
    Bianca Scolaro, Hellen Soo Jin Kim, Inar Alves de Castro · 2016 · Critical Reviews in Food Science and Nutrition
  79. Pharmacological modulation of vascular ageing: A review from VascAgeNet
    Lynn Roth, Soner Doğan, Bilge Güvenç Tuna, Tamás Arányi, Sònia Benı́tez, María Borrell-Pagés, Perinur Bozaykut, Guido R.Y. De Meyer, Laurent Duca, Nergiz Durmuş et al. · 2023 · Ageing Research Reviews
  80. The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors: an updated systematic review of randomized controlled trials
    Gyu Yeong Choi, Philip C. Calder · 2024 · Frontiers in Nutrition
  81. N-3 Fatty Acids for Prevention of Cardiovascular Disease
    Owais A. Khawaja, J. Michael Gaziano, Luc Djoussé · 2014 · Current Atherosclerosis Reports
  82. History and future of omega-3 fatty acids in cardiovascular disease
    Sperling, Laurence S., Nelson, John R. · 2016 · Current Medical Research and Opinion
  83. Associations between Serum Omega-3 Fatty Acid Levels and Cognitive Functions among Community-Dwelling Octogenarians in Okinawa, Japan: The KOCOA Study
    Junko Nishihira, Takashi Tokashiki, Yasushi Higashiuesato, D. Craig Willcox, Nora Mattek, Lynne H. Shinto, Yusuke Ohya, Hiroko Hayama Dodge · 2016 · Journal of Alzheimer s Disease
  84. Metabolomics of Spleen-Yang deficiency syndrome and the therapeutic effect of Fuzi Lizhong pill on regulating endogenous metabolism
    Zhen Zhang, Shasha Yang, Lin Xia, You Huang, Xinyi Wei, Jinwei Zhou, Rui Li, Bin Deng, Chaomei Fu · 2021 · Journal of Ethnopharmacology
  85. Role of omega-3 fatty acids in the prevention and treatment of cardiovascular Diseases: A consensus statement from the Experts’ Committee Of National Society Of Cardiometabolic Medicine
    Jian‐Jun Li, Kefei Dou, Zhiguang Zhou, Dong Hui Zhao, Ping Ye, Jiajun Zhao, Lixin Guo · 2022 · Frontiers in Pharmacology
  86. Preoperative carbohydrate load and intraoperatively infused omega-3 polyunsaturated fatty acids positively impact nosocomial morbidity after coronary artery bypass grafting: a double-blind controlled randomized trial
    Gibran Roder Feguri, Paulo Ruiz Lúcio de Lima, Danilo de Cerqueira Borges, Laura Ramos Toledo, Larissa Nadaf Batista, Thaís Carvalho e Silva, Neuber José Segri, José Eduardo de Aguilar‐Nascimento · 2017 · Nutrition Journal
  87. n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: Principles, Practices, Pitfalls, and Promises - A Contemporary Review
    RICHARD J. KONES, Scott L. Howell, Umme Rumana · 2017 · Medical Principles and Practice
  88. Impact of Different Doses of Omega-3 Fatty Acids on Cardiovascular Outcomes: a Pairwise and Network Meta-analysis
    Lombardi, Marco, Chiabrando, Juan G., Vescovo, Giovanni M., Bressi, Edoardo, Del Buono, Marco Giuseppe, Carbone, Salvatore, Koenig, Rachel A., Van Tassell, Benjamin W., Abbate, Antonio, Biondi-Zoccai, Giuseppe et al. · 2020 · Current Atherosclerosis Reports
  89. Role of polyunsaturated fatty acids in ischemic stroke – A perspective of specialized pro-resolving mediators
    Zhijuan Miao, Marianne Schultzberg, Xiuzhe Wang, Yuwu Zhao · 2021 · Clinical Nutrition
  90. The Role of Nutrition in the Risk and Burden of Stroke
    Graeme J. Hankey · 2017 · Stroke
  91. Herbal medications and other dietary supplements. A clinical review for physicians caring for older people
    Kaisu Hannele Pitkälä, Merja H. Suominen, J. Simon Bell, Timo E. Strandberg · 2016 · Annals of Medicine
  92. Management of fatty liver disease with the metabolic syndrome
    Mariana Verdelho Machado, Helena Cortez‐Pinto · 2014 · Expert Review of Gastroenterology & Hepatology
  93. Omega‐3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism
    Martin F. Reiner, Simona Stivala, Andreas Limacher, Nicole R. Bonetti, Marie Méan, Michael Egloff, Nicolas Rodondi, Drahomir Aujesky, Clemens von Schacky, Thomas Felix Lüscher et al. · 2017 · Journal of Thrombosis and Haemostasis
  94. Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?
    Evangelos C. Rizos, Moses Elisaf · 2017 · Current Cardiology Reports
  95. Dietary fats and cardiovascular health: a summary of the scientific evidence and current debate
    Elena Fattore, Elena Massa · 2018 · International Journal of Food Sciences and Nutrition
  96. Effect of Dietary Counseling on a Comprehensive Metabolic Profile from Childhood to Adulthood
    Miia Lehtovirta, Katja Pahkala, Harri Niinikoski, Antti J. Kangas, Pasi Soininen, Hanna Lagström, Jorma S.A. Viikari, Tapani Rönnemaa, Antti Jula, Mika Ala‐Korpela et al. · 2018 · The Journal of Pediatrics
  97. Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol
    Shen Tian, Guoqiang Xing, Jingfen Zhu, Shuxian Zhang, Yong Cai, Donghua Li, Gang Xu, Evan Xing, Jianyu Rao, Rong Shi · 2017 · Lipids in Health and Disease
  98. Drug Therapy of Dyslipidemia in the Elderly
    Srikanth Yandrapalli, Shashvat Gupta, Gabriela Andries, Howard A. Cooper, Wilbert S. Aronow · 2019 · Drugs & Aging
  99. Current and Emerging Trends in the Formulation and Manufacture of Nutraceuticals and Functional Food Products
    Alberta N. A. Aryee, Joyce I. Boye · 2014 · Wiley eBooks
  100. Effect of ω-3 Fatty Acid Ethyl Esters on Apolipoprotein B-48 Kinetics in Obese Subjects on a Weight-Loss Diet: A New Tracer Kinetic Study in the Postprandial State
    Wong, Annette T. Y., Chan, Dick C., Barrett, P. Hugh R., Adams, Leon A., Watts, Gerald F. · 2014 · The Journal of Clinical Endocrinology & Metabolism